rs11018874

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005467.4(NAALAD2):​c.195-5061G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.1 in 152,026 control chromosomes in the GnomAD database, including 1,288 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1288 hom., cov: 32)

Consequence

NAALAD2
NM_005467.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.230

Publications

13 publications found
Variant links:
Genes affected
NAALAD2 (HGNC:14526): (N-acetylated alpha-linked acidic dipeptidase 2) This gene is a member of the N-acetylated alpha-linked acidic dipeptidase (NAALADase) gene family. The representative member of this family is the gene encoding human prostate-specific membrane antigen (PSM), which is a marker of prostatic carcinomas and is the first to be shown to possess NAALADase activity. NAALADase cleaves N-acetyl-L-aspartate-L-glutamate (NAAG), which is a neuropeptide expressed both in the central nervous systems and in the periphery and is thought to function as a neurotransmitter. The product of this gene is a type II integral membrane protein. Transient transfection of this gene confers both NAALADase and dipetidyl peptidase IV activities to mammalian cells. This gene is highly expressed in ovary and testis as well as within discrete brain areas. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005467.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005467.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAALAD2
NM_005467.4
MANE Select
c.195-5061G>A
intron
N/ANP_005458.1Q9Y3Q0-1
NAALAD2
NM_001300930.2
c.195-5061G>A
intron
N/ANP_001287859.1J3KNJ3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAALAD2
ENST00000534061.6
TSL:1 MANE Select
c.195-5061G>A
intron
N/AENSP00000432481.1Q9Y3Q0-1
NAALAD2
ENST00000375944.7
TSL:1
c.195-5061G>A
intron
N/AENSP00000365111.3Q9Y3Q0-2
NAALAD2
ENST00000524501.1
TSL:1
n.255-5061G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.100
AC:
15260
AN:
151908
Hom.:
1280
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0214
Gnomad AMI
AF:
0.0484
Gnomad AMR
AF:
0.264
Gnomad ASJ
AF:
0.0524
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.168
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0935
Gnomad OTH
AF:
0.0954
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.100
AC:
15273
AN:
152026
Hom.:
1288
Cov.:
32
AF XY:
0.108
AC XY:
8038
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.0213
AC:
885
AN:
41494
American (AMR)
AF:
0.265
AC:
4046
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0524
AC:
182
AN:
3470
East Asian (EAS)
AF:
0.245
AC:
1264
AN:
5164
South Asian (SAS)
AF:
0.103
AC:
498
AN:
4814
European-Finnish (FIN)
AF:
0.168
AC:
1778
AN:
10564
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.0935
AC:
6357
AN:
67958
Other (OTH)
AF:
0.0939
AC:
198
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
636
1272
1908
2544
3180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0986
Hom.:
3305
Bravo
AF:
0.107
Asia WGS
AF:
0.142
AC:
496
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
2.1
DANN
Benign
0.47
PhyloP100
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11018874;
hg19: chr11-89875437;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.